National HealthCare Valuation
| NHC Stock | USD 125.20 0.73 0.59% |
At this time, the firm appears to be overvalued. National HealthCare secures a last-minute Real Value of $65.82 per share. The latest price of the firm is $125.2. Our model forecasts the value of National HealthCare from analyzing the firm fundamentals such as Profit Margin of 0.10 %, current valuation of 1.92 B, and Return On Equity of 0.13 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting National HealthCare's valuation include:
Price Book 1.9657 | Enterprise Value 1.9 B | Enterprise Value Ebitda 9.069 | Price Sales 1.5804 | Trailing PE 15.4368 |
Overvalued
Today
Please note that National HealthCare's price fluctuation is very steady at this time. Calculation of the real value of National HealthCare is based on 3 months time horizon. Increasing National HealthCare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since National HealthCare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of National Stock. However, National HealthCare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 125.2 | Real 65.82 | Target 6.15 | Hype 125.01 |
The real value of National Stock, also known as its intrinsic value, is the underlying worth of National HealthCare Company, which is reflected in its stock price. It is based on National HealthCare's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of National HealthCare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of National HealthCare helps investors to forecast how National stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of National HealthCare more accurately as focusing exclusively on National HealthCare's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use National HealthCare's intrinsic value based on its ongoing forecasts of National HealthCare's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against National HealthCare's closest peers. If more than one evaluation category is relevant for National HealthCare we suggest using both methods to arrive at a better estimate.
National HealthCare Cash |
|
National Valuation Trend
Comparing National HealthCare's enterprise value against its market capitalization is a good way to estimate the value of National HealthCare uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
National Revenue by Product
National HealthCare Total Value Analysis
National HealthCare is now forecasted to have company total value of 1.92 B with market capitalization of 1.9 B, debt of 93.39 M, and cash on hands of 58.67 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the National HealthCare fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.92 B | 1.9 B | 93.39 M | 58.67 M |
National HealthCare Investor Information
About 20.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.97. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. National HealthCare recorded earning per share (EPS) of 7.99. The entity last dividend was issued on the 30th of December 2024. Based on the measurements of operating efficiency obtained from National HealthCare's historical financial statements, National HealthCare may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.0908 | 0.05 |
|
| |||||
| Total Cash From Operating Activities | 66.6 M | 111.2 M |
|
| |||||
| Operating Income | 53.7 M | 57.1 M |
|
|
National HealthCare Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. National HealthCare has an asset utilization ratio of 87.09 percent. This indicates that the Company is making $0.87 for each dollar of assets. An increasing asset utilization means that National HealthCare is more efficient with each dollar of assets it utilizes for everyday operations.National HealthCare Ownership Allocation
National HealthCare maintains a total of 15.44 Million outstanding shares. Over half of National HealthCare's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.National HealthCare Profitability Analysis
The company reported the last year's revenue of 1.14 B. Total Income to common stockholders was 66.8 M with profit before taxes, overhead, and interest of 388.11 M.National HealthCare Past Distributions to stockholders
| 1st of November 2024 | ||
| 1st of August 2024 | ||
| 1st of May 2024 | ||
| 1st of February 2024 | ||
| 1st of November 2023 | ||
| 31st of July 2023 | ||
| 1st of May 2023 | ||
| 1st of February 2023 |
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates National HealthCare's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in National HealthCare and how it compares across the competition.
About National HealthCare Valuation
The stock valuation mechanism determines National HealthCare's current worth on a weekly basis. Our valuation model uses a comparative analysis of National HealthCare. We calculate exposure to National HealthCare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of National HealthCare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 429.2 M | 347.7 M | |
| Pretax Profit Margin | 0.08 | 0.06 | |
| Operating Profit Margin | 0.05 | 0.09 | |
| Net Profit Margin | 0.06 | 0.05 | |
| Gross Profit Margin | 0.38 | 0.57 |
A single share of National HealthCare represents a small ownership stake in the entity. As a stockholder of National, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
National HealthCare Dividends Analysis For Valuation
At present, National HealthCare's Dividend Paid And Capex Coverage Ratio is projected to increase slightly based on the last few years of reporting. . At present, National HealthCare's Earnings Yield is projected to slightly decrease based on the last few years of reporting. The current year's Price Earnings Ratio is expected to grow to 22.24, whereas Retained Earnings Total Equity is forecasted to decline to about 448.2 M.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | -35.6 M | -33.8 M | |
| Dividend Yield | 0.03 | 0.04 | |
| Dividend Payout Ratio | 0.53 | 0.39 | |
| Dividend Paid And Capex Coverage Ratio | 1.75 | 1.88 |
There are various types of dividends National HealthCare can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of National shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from National HealthCare directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When National pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of National HealthCare by the value of the dividends paid out.
National HealthCare Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 15.4 M | |
| Quarterly Earnings Growth Y O Y | 3.021 |
National HealthCare Current Valuation Indicators
Valuation refers to the process of determining the present value of National HealthCare and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value National we look at many different elements of the entity such as National's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as National HealthCare, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use National HealthCare's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes National HealthCare's worth.Complementary Tools for National Stock analysis
When running National HealthCare's price analysis, check to measure National HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National HealthCare is operating at the current time. Most of National HealthCare's value examination focuses on studying past and present price action to predict the probability of National HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National HealthCare's price. Additionally, you may evaluate how the addition of National HealthCare to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |